Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cytokines and chemokines in multiple sclerosis.
Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Neuroinflammation: Transport disruption in multiple sclerosis.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Towards a Quantitative OCT Image Analysis.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
Microanatomy and histological features of central myelin in the root exit zone of facial nerve.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
Multiple sclerosis patients' experiences in relation to the impact of the kinect virtual home-exercise programme: a qualitative study.
Current and new directions in MRI in multiple sclerosis.
Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.
CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.
BG-12 in Multiple Sclerosis.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
Axon-glia interaction and membrane traffic in myelin formation.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »